Health Care & Hospital Law,
Civil Litigation
Jun. 29, 2021
Drug companies open defense with opioid advocate
Four opioid manufacturers are accused by four California communities of false advertising and creating a public nuisance by allegedly downplaying the risks of opioid addiction in their marketing.
Pharmaceutical companies accused of fueling the opioid crisis in California began their case in chief Monday in a $50 billion bench trial in Orange County.
Four opioid manufacturers including Allergan PLC, the maker of the morphine pill Kadian, are accused by four California communities of false advertising and creating a public nuisance by allegedly downplaying the risks of opioid addiction in their marketing.
$95
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
